HUM 股价正升至 52 周新高，受政府估值评级改善及潜在收入增长推动。
逐段跳播
我们来看看Humana今天早上的表现如何。Humana的股价今天早上出现反弹，这完全得益于有关估值好于预期的好消息。这是华尔街密切关注的一项指标。
We're looking at Humana to see how they did this morning. Humana's shares are seeing a rebound this morning, all thanks to good news regarding better-than-expected valuations. It is a metric that Wall Street pays close attention to.
Medicare和Medicaid已公布其2027年评级。这对这家健康保险公司来说是一次重大转变。你可以从股价表现中看到这一点，目前股价已上涨超过15%，在今年以来已有涨幅的基础上进一步走高。
Medicare and Medicaid have released their 2027 rankings. It has been a significant shift for the health insurance company. You can see that reflected in the performance of stocks, which are now up by more than 15%, adding to the gains we have seen so far this year.
因此，他们现在许多计划的评级变成了四星。该公司表示，95%的Medicare Advantage参保人目前参加的是四星或更高评级的计划。
As a result, they now have a four-star rating instead in many of their plans. The company says that 95% of Medicare Advantage subscribers are now enrolled in plans rated four stars or higher.
这对Humana来说是一场重大胜利，该公司两年前评级曾大幅下滑。而今年，该公司再次成为最大的赢家之一。
It's a big win for Humana, which saw its ratings plummet two years ago. And now again this year, the company has been one of the biggest winners.
这可能在整个板块转化为数十亿美元的额外收入。因此，Medicare Advantage今年的总质量奖励预计将超过130亿。因此，更好的估值可以提升Humana未来的收入和盈利能力。
This could translate into billions of dollars in additional revenue across the entire sector. Therefore, Medicare Advantage's total quality rewards this year are expected to exceed 13 billion.
Therefore, better valuations can boost Humana's future revenue and profitability.
至于华尔街的反应，Baird相应地上调了Humana的评级。他们将其评级从“中性”上调至“出色表现”。这直接发生在政府公布这些评估之后。他们将其目标价上调至596美元。这高于此前的390美元，比他们此前预期的涨幅超过50%。
As for Wall Street's response, Baird upgraded Humana's rating accordingly. They upgraded its rating from "neutral" to "outstanding performance". This comes directly after the government announced these assessments.
They have raised their price target to $596. This is up from $390, an increase of more than 50% over what they had previously expected.
他们对Humana到2028年实现超过35美元调整后每股收益的能力更有信心。三个关键驱动因素是：Medicare Advantage的星级评级、他们认为将保护盈利能力的定价和福利决策，以及全国范围内Medicare Advantage成本增长放缓的预期。
They have greater confidence in Humana's ability to generate more than $35 in adjusted earnings per share by 2028. Three key drivers are: Medicare Advantage's star ratings, pricing and benefit decisions they believe will protect profitability, and expectations of slower Medicare Advantage cost growth nationwide.
所以，这里的大局是，Humana因此正在走高。并创下52周内的新高。
So, the big picture here is that Humana is on the rise as a result. And new record levels within 52 weeks.
这个频道对 $HUM 的历次判断
Schwab Network 在这只股票上只有这一条判断。